Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study

Damien Giacchero; Vincent Sibaud; Emilie Gerard; Celeste Lebbe; Jesse Hirner; Olivier Gaide; Vassiliki Nikolaou; Pietro Sollena; Chryssa Oikonomou; Emma Huard; Thierry Passeron; Johana Rousset; Michela Starace; Francesca Bruni; Priscila Giavedoni; Azael Freites-Martinez; Davide Fattore; Ana Clara Torre; Alicia Jimenez-Anton; Cristina Carrera; Dimitra Koumaki; Florentina Delli; Yannick S. Elshot; Julia Riganti; Lukas Kraehenbuehl; Konstantinos Lallas; Zoe Apalla

doi:10.1111/jdv.70122

Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study

Damien Giacchero
, Vincent Sibaud
, Emilie Gerard
, Celeste Lebbe
, Jesse Hirner
, Olivier Gaide
, Vassiliki Nikolaou
, Pietro Sollena
, Chryssa Oikonomou
, Emma Huard
, Thierry Passeron
, Johana Rousset
, Michela Starace
, Francesca Bruni
, Priscila Giavedoni
, Azael Freites-Martinez
, Davide Fattore
, Ana Clara Torre
, Alicia Jimenez-Anton
, Cristina Carrera

Dimitra Koumaki, Florentina Delli, Yannick S. Elshot, Julia Riganti, Lukas Kraehenbuehl, Konstantinos Lallas, Zoe Apalla^*

^*Corresponding author for this work

Centre Hospitalier Universitaire de Nice
Institut Universitaire du Cancer
Service d'information médicale
Université Paris Cité
University of Missouri
University of Lausanne
National and Kapodistrian University of Athens
Fondazione Policlinico Universitario IRCCS
University of Patras
Université Côte d'Azur
Centre Méditerranéen de Médecine Moléculaire
CHU de Nice
University of Bologna
University of Barcelona
Universidad Europea
University of Naples Federico II
Hospital Italiano de Buenos Aires
Hospital Universitario Puerta del Mar
Heraklion University Hospital
Hippokratia Hospital
Netherlands Cancer Institute
University of Amsterdam
University of Zurich
Aristotle University of Thessaloniki

Research output: Contribution to journal › Comment/Letter to the editor › Academic

5 Downloads (Pure)

Original language	English
Journal	Journal of the European Academy of Dermatology and Venereology
Early online date	2025
DOIs	https://doi.org/10.1111/jdv.70122
Publication status	E-pub ahead of print - 2025

Keywords

dermatitis
dupilumab
immune checkpoint inhibitors
immune-related adverse events
nivolumab
pembrolizumab
pruritus

Access to Document

10.1111/jdv.70122

Dupilumab-for-immune-checkpoint-inhibitors-induced-pruritic-dermatoses.pdfFinal published version, 245 KBLicence: Taverne

Cite this

Giacchero, D., Sibaud, V., Gerard, E., Lebbe, C., Hirner, J., Gaide, O., Nikolaou, V., Sollena, P., Oikonomou, C., Huard, E., Passeron, T., Rousset, J., Starace, M., Bruni, F., Giavedoni, P., Freites-Martinez, A., Fattore, D., Torre, A. C., Jimenez-Anton, A., ... Apalla, Z. (2025). Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study. Journal of the European Academy of Dermatology and Venereology. Advance online publication. https://doi.org/10.1111/jdv.70122

@article{316a4cbc5ed040b3ae20a9d39dfb4acc,

title = "Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study",

keywords = "dermatitis, dupilumab, immune checkpoint inhibitors, immune-related adverse events, nivolumab, pembrolizumab, pruritus",

author = "Damien Giacchero and Vincent Sibaud and Emilie Gerard and Celeste Lebbe and Jesse Hirner and Olivier Gaide and Vassiliki Nikolaou and Pietro Sollena and Chryssa Oikonomou and Emma Huard and Thierry Passeron and Johana Rousset and Michela Starace and Francesca Bruni and Priscila Giavedoni and Azael Freites-Martinez and Davide Fattore and Torre, \{Ana Clara\} and Alicia Jimenez-Anton and Cristina Carrera and Dimitra Koumaki and Florentina Delli and Elshot, \{Yannick S.\} and Julia Riganti and Lukas Kraehenbuehl and Konstantinos Lallas and Zoe Apalla",

year = "2025",

doi = "10.1111/jdv.70122",

language = "English",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley Blackwell",

}

Giacchero, D, Sibaud, V, Gerard, E, Lebbe, C, Hirner, J, Gaide, O, Nikolaou, V, Sollena, P, Oikonomou, C, Huard, E, Passeron, T, Rousset, J, Starace, M, Bruni, F, Giavedoni, P, Freites-Martinez, A, Fattore, D, Torre, AC, Jimenez-Anton, A, Carrera, C, Koumaki, D, Delli, F, Elshot, YS, Riganti, J, Kraehenbuehl, L, Lallas, K & Apalla, Z 2025, 'Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study', Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70122

TY - JOUR

T1 - Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses

T2 - A retrospective, multicentric study

AU - Giacchero, Damien

AU - Sibaud, Vincent

AU - Gerard, Emilie

AU - Lebbe, Celeste

AU - Hirner, Jesse

AU - Gaide, Olivier

AU - Nikolaou, Vassiliki

AU - Sollena, Pietro

AU - Oikonomou, Chryssa

AU - Huard, Emma

AU - Passeron, Thierry

AU - Rousset, Johana

AU - Starace, Michela

AU - Bruni, Francesca

AU - Giavedoni, Priscila

AU - Freites-Martinez, Azael

AU - Fattore, Davide

AU - Torre, Ana Clara

AU - Jimenez-Anton, Alicia

AU - Carrera, Cristina

AU - Koumaki, Dimitra

AU - Delli, Florentina

AU - Elshot, Yannick S.

AU - Riganti, Julia

AU - Kraehenbuehl, Lukas

AU - Lallas, Konstantinos

AU - Apalla, Zoe

PY - 2025

Y1 - 2025

KW - dermatitis

KW - dupilumab

KW - immune checkpoint inhibitors

KW - immune-related adverse events

KW - nivolumab

KW - pembrolizumab

KW - pruritus

UR - https://www.scopus.com/pages/publications/105019244796

U2 - 10.1111/jdv.70122

DO - 10.1111/jdv.70122

M3 - Comment/Letter to the editor

C2 - 41099465

SN - 0926-9959

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

Dupilumab for immune checkpoint inhibitors-induced pruritic dermatoses: A retrospective, multicentric study

Keywords

Access to Document

Other files and links

Cite this